Asclemed USA Inc. recalls
4 recalls filed under Asclemed USA Inc.. The most recent was published July 29, 2026.
-
Class III · 3 months ago
Asclemed USA Inc. Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% vial recall: Labeling: Not Elsewhere Classified: The label wrap covers the barcode
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
-
Class II · 4 months ago
Asclemed USA Inc. Lidocaine HCl Injection USP, 1% , 5 mL single dose ampule recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 4 months ago
Asclemed USA Inc. Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 5 months ago
Asclemed USA Inc. Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx recall: CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity
CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.
About this page
Asclemed USA Inc. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.